ElizaYankova Cambridge Stem Cell Institute, University of CambridgeUnited Kingdom

• mRNA based therapeutics against cancer
  MustafaDiken Speaker BioNTech AGGermany
• Proffered Paper: Pharmacological targeting of METTL1 as a novel anti-cancer strategy
  EACR26-1904
  EACR26-1904
  ElizaYankova Oral Presenter Cambridge Stem Cell Institute, University of CambridgeUnited Kingdom
• A-to-I RNA Editing in Cancer
  ErezLevanon Speaker The Goodman Faculty of Life SciencesIsrael
• Proffered Paper: Defining NXT1:NXF1-mediated RNA export as a colorectal cancer-specific vulnerability
  EACR26-0946
  EACR26-0946
  VidaKufrin Oral Presenter National Center for Tumor Diseases (NCT) DresdenGermany
• Targeting RNA Methylases in Cancer Therapy: A Novel Approach to Revolutionize Treatment
  SandraBlanco Benavente Speaker Universidad de SalamancaSpain